11/3/2026

speaker
Conference Operator
Operator

Good morning and welcome to the Sotera Health third quarter 2026 conference call. All participants will be in a listen-only mode. Should you need assistance, please signal conference specialists by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star, then one on your touch-tone phone. To withdraw from the question queue, You may press star then two. Please note, this event is being recorded. I would now like to turn the conference call over to Vice President of Investor Relations, Mr. Jason Peterson. Mr. Peterson, the floor is yours, sir.

speaker
Jason Peterson
Vice President of Investor Relations, Sotera Health

Good morning and welcome to Sotera Health's third quarter earnings call. Today's press release and earnings presentation are available on the investor section of our website at soterahealth.com. This webcast is being recorded, and a replay will also be available on the investor section of the Sotera Health website shortly after the call. Joining me today are Chief Executive Officer Alton Shader, Chief Financial Officer John Lyons, and Executive Chairman Michael Petras. During today's call, some of our comments may be considered forward-looking statements. The matters addressed in these statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected or implied. Please refer to Sotera Health's SEC filings in the forward-looking statement slide at the beginning of the earnings presentation for a description of these risks and uncertainties. The company assumes no obligation to update any such forward-looking statements. Please note that during the discussion today, the company will present both GAAP and non-GAAP financial measures including adjusted EBITDA, adjusted EBITDA margin, tax rate applicable to adjusted net income, Adjusted net income, adjusted EPS, net debt, and net leverage ratio, as well as constant currency comparisons. A reconciliation of gap to non-gap measures for all relevant historical periods may be found in the schedules attached to the company's press release and in the supplemental slides to the earnings presentation. The operator will be assisting with the Q&A portion of the call today. Please limit yourself to one question and one follow-up. For further questions, feel free to reach out to the investor relations team. I will now turn the call over to Sotera Health CEO, Alton Shader.

speaker
Alton Shader
Chief Executive Officer, Sotera Health

Good morning and thank you for joining us. Today we reported solid top and bottom line growth versus the third quarter of 2025, driven by strong execution and sequential adjusted EBITDA margin improvement of nearly 100 basis points. For the third quarter, we delivered constant currency revenue growth of 4.4%, and Constant Currency adjusted EBITDA growth of 4% versus the same period last year. Sterigenics continued to perform well, generating 8.2% constant currency revenue growth and 57 basis points of segment income margin expansion, despite experiencing some softness in the med device market during the quarter, which has continued into the early part of Q4. Nelson Labs delivered another strong quarter, with revenue increasing 9.2% on a constant currency basis as the team continued to execute on complex projects to support our customers' regulatory needs. As expected, Nordion results reflected the timing of Cobalt 60 harvest schedules. The Nordion teams did a great job delivering critical Cobalt 60 shipments for their customers and expanded segment income margins by 71 basis points. Based on our year-to-date performance and our current visibility into the remainder of the year, we are reaffirming our constant currency revenue and adjusted EBITDA outlook for 2026. At Sotera Health, we work tirelessly to help ensure the safety and availability of healthcare products that millions of patients rely on every day. Before John reviews the financials in more detail, I want to provide some additional context around an example we shared on our second quarter call that highlights how our teams make a meaningful difference for customers and patients. As we've discussed previously, customers regularly turn to Nelson Labs when they face time-sensitive and complex challenges. During the second and third quarters, a customer of ours faced an urgent regulatory testing need involving a product used in a significant percentage of surgeries performed around the world. The Nelson Labs team quickly mobilized its scientific and technical expertise, completed the required testing on an accelerated timeline, and helped the customer maintain the availability of a critical healthcare product. While this was one project, the impact was far broader. By helping our customer address a time-sensitive challenge, our team played an important role in supporting tens of millions of patients who rely on these critical medical procedures. This is exactly what we mean when we talk about putting customers first and delivering on our mission of safeguarding global health. I will now hand it off to John, who will walk us through the financials.

Want transcripts like this in your own app? Try the Earnings call API, or read the transcript API docs.

Disclaimer

This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

-

-

Use this data in your own app

Pull this call's transcript, audio and slides with the Earnings call transcripts API.

See pricing

9,000+ companies · REST API

Investor presentation